215 related articles for article (PubMed ID: 27811150)
21. Hypoxia controls the expression of genes responsible for serine synthesis in U87MG cells on ERN1-dependent manner.
Sliusar MY; Minchenko DO; Khita OO; Tsymbal DO; Viletska YM; Luzina OY; Danilovskyi SV; Ratushna OO; Minchenko OH
Endocr Regul; 2023 Jan; 57(1):252-261. PubMed ID: 37823569
[No Abstract] [Full Text] [Related]
22. Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer.
Unterlass JE; Baslé A; Blackburn TJ; Tucker J; Cano C; Noble MEM; Curtin NJ
Oncotarget; 2018 Mar; 9(17):13139-13153. PubMed ID: 29568346
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of phosphoglycerate dehydrogenase in breast cancer.
Chandrika M; Chua PJ; Muniasamy U; Huang RYJ; Thike AA; Ng CT; Tan PH; Yip GW; Bay BH
Breast Cancer Res Treat; 2021 Apr; 186(3):655-665. PubMed ID: 33625616
[TBL] [Abstract][Full Text] [Related]
24. The NAD
Murphy JP; Giacomantonio MA; Paulo JA; Everley RA; Kennedy BE; Pathak GP; Clements DR; Kim Y; Dai C; Sharif T; Gygi SP; Gujar S
Cell Rep; 2018 Aug; 24(9):2381-2391.e5. PubMed ID: 30157431
[TBL] [Abstract][Full Text] [Related]
25. PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.
Rossi M; Altea-Manzano P; Demicco M; Doglioni G; Bornes L; Fukano M; Vandekeere A; Cuadros AM; Fernández-García J; Riera-Domingo C; Jauset C; Planque M; Alkan HF; Nittner D; Zuo D; Broadfield LA; Parik S; Pane AA; Rizzollo F; Rinaldi G; Zhang T; Teoh ST; Aurora AB; Karras P; Vermeire I; Broekaert D; Elsen JV; Knott MML; Orth MF; Demeyer S; Eelen G; Dobrolecki LE; Bassez A; Brussel TV; Sotlar K; Lewis MT; Bartsch H; Wuhrer M; Veelen PV; Carmeliet P; Cools J; Morrison SJ; Marine JC; Lambrechts D; Mazzone M; Hannon GJ; Lunt SY; Grünewald TGP; Park M; Rheenen JV; Fendt SM
Nature; 2022 May; 605(7911):747-753. PubMed ID: 35585241
[TBL] [Abstract][Full Text] [Related]
26. Multi-omics Analysis of the Role of PHGDH in Colon Cancer.
Dai Z; Chen L; Pan K; Zhao X; Xu W; Du J; Xing C
Technol Cancer Res Treat; 2023; 22():15330338221145994. PubMed ID: 36707056
[No Abstract] [Full Text] [Related]
27. 3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.
Li M; Wu C; Yang Y; Zheng M; Yu S; Wang J; Chen L; Li H
Cell Oncol (Dordr); 2021 Jun; 44(3):541-556. PubMed ID: 33735398
[TBL] [Abstract][Full Text] [Related]
28. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate.
Pacold ME; Brimacombe KR; Chan SH; Rohde JM; Lewis CA; Swier LJ; Possemato R; Chen WW; Sullivan LB; Fiske BP; Cho S; Freinkman E; Birsoy K; Abu-Remaileh M; Shaul YD; Liu CM; Zhou M; Koh MJ; Chung H; Davidson SM; Luengo A; Wang AQ; Xu X; Yasgar A; Liu L; Rai G; Westover KD; Vander Heiden MG; Shen M; Gray NS; Boxer MB; Sabatini DM
Nat Chem Biol; 2016 Jun; 12(6):452-8. PubMed ID: 27110680
[TBL] [Abstract][Full Text] [Related]
29. Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression.
Barnabas GD; Lee JS; Shami T; Harel M; Beck L; Selitrennik M; Jerby-Arnon L; Erez N; Ruppin E; Geiger T
Cancer Res; 2021 Mar; 81(6):1443-1456. PubMed ID: 33500247
[TBL] [Abstract][Full Text] [Related]
30. Acetylation Stabilizes Phosphoglycerate Dehydrogenase by Disrupting the Interaction of E3 Ligase RNF5 to Promote Breast Tumorigenesis.
Wang C; Wan X; Yu T; Huang Z; Shen C; Qi Q; Xiang S; Chen X; Arbely E; Ling ZQ; Liu CY; Yu W
Cell Rep; 2020 Aug; 32(6):108021. PubMed ID: 32783943
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype.
Semenza GL
EMBO J; 2017 Feb; 36(3):252-259. PubMed ID: 28007895
[TBL] [Abstract][Full Text] [Related]
32. An epitope tag alters phosphoglycerate dehydrogenase structure and impairs ability to support cell proliferation.
Mattaini KR; Brignole EJ; Kini M; Davidson SM; Fiske BP; Drennan CL; Vander Heiden MG
Cancer Metab; 2015; 3():5. PubMed ID: 25926973
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics analysis of the serine and glycine pathway in cancer cells.
Antonov A; Agostini M; Morello M; Minieri M; Melino G; Amelio I
Oncotarget; 2014 Nov; 5(22):11004-13. PubMed ID: 25436979
[TBL] [Abstract][Full Text] [Related]
34. Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth.
Chen J; Chung F; Yang G; Pu M; Gao H; Jiang W; Yin H; Capka V; Kasibhatla S; Laffitte B; Jaeger S; Pagliarini R; Chen Y; Zhou W
Oncotarget; 2013 Dec; 4(12):2502-11. PubMed ID: 24318446
[TBL] [Abstract][Full Text] [Related]
35. PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis.
Zhang B; Zheng A; Hydbring P; Ambroise G; Ouchida AT; Goiny M; Vakifahmetoglu-Norberg H; Norberg E
Cell Rep; 2017 Jun; 19(11):2289-2303. PubMed ID: 28614715
[TBL] [Abstract][Full Text] [Related]
36. Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity.
Wang Q; Liberti MV; Liu P; Deng X; Liu Y; Locasale JW; Lai L
Cell Chem Biol; 2017 Jan; 24(1):55-65. PubMed ID: 28042046
[TBL] [Abstract][Full Text] [Related]
37. Identification of Novel Natural Inhibitors to Human 3-Phosphoglycerate Dehydrogenase (PHGDH) for Cancer Treatment.
Sadiqa A; Rasul A; Hassan M; Sultana S; Jabeen F
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144843
[TBL] [Abstract][Full Text] [Related]
38. PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma.
D'Avola A; Legrave N; Tajan M; Chakravarty P; Shearer RL; King HW; Kluckova K; Cheung EC; Clear AJ; Gunawan AS; Zhang L; James LK; MacRae JI; Gribben JG; Calado DP; Vousden KH; Riches JC
J Clin Invest; 2022 May; 132(9):. PubMed ID: 35316216
[TBL] [Abstract][Full Text] [Related]
39. Serine synthesis through PHGDH coordinates nucleotide levels by maintaining central carbon metabolism.
Reid MA; Allen AE; Liu S; Liberti MV; Liu P; Liu X; Dai Z; Gao X; Wang Q; Liu Y; Lai L; Locasale JW
Nat Commun; 2018 Dec; 9(1):5442. PubMed ID: 30575741
[TBL] [Abstract][Full Text] [Related]
40. A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism.
Zhao JY; Feng KR; Wang F; Zhang JW; Cheng JF; Lin GQ; Gao D; Tian P
Eur J Med Chem; 2021 May; 217():113379. PubMed ID: 33756126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
